Bashkiria State Medical University

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• High blood pressure1 trial
• Psoriasis1 trial
• Pulmonary arterial hypertension1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Actelion1 trial
• Amgen1 trial

Closed trials

• Completed

  A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

  NCT04175613· Phase 3· Amgen· Source

• Completed

  A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

  NCT02932410· Phase 3· Actelion· Source